Phenotype, function, and differentiation potential of human monocyte subsets.

Boyette LB, Macedo C, Hadi K, Elinoff BD, Walters JT, Ramaswami B, Chalasani G, Taboas JM, Lakkis FG, Metes DM. · 2017

Read Phenotype, function, and differentiation potential of human monocyte subsets. by Boyette LB, Macedo C, Hadi K, Elinoff BD, Walters JT, Ramaswami B, Chalasani G, Taboas JM, Lakkis FG, Metes DM. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5406034.txt.

Introduction

Lisa B. Boyette and nine co-authors sort out the types of human monocytes in a 2017 paper in PLoS ONE. Monocytes are white blood cells that fight germs, clear dead cells, and can mature into other immune cells. They fall into three groups by surface markers: classical, intermediate, and non-classical. Past records of what each group does, and what each can become, were patchy, so the team tested fresh blood from healthy donors.

Group shares stayed steady over time and across people. Classical cells made the most alarm signals when provoked and were the main source of one key cell type used to start immune responses. Non-classical cells were the least reactive to most probes but led in making an antiviral signal. All three groups could mature into macrophages, the large eater cells of tissues.

Catalog record

CREATORBoyette LB, Macedo C, Hadi K, Elinoff BD, Walters JT, Ramaswami B, Chalasani G, Taboas JM, Lakkis FG, Metes DM.
YEAR2017
COLLECTIONPAPERS
FORMATTXT
FILE SIZE53 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5406034

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Phenotype, function, and differentiation potential of human monocyte subsets By Lisa B. Boyette, Camila Macedo, Kevin Hadi, Beth D. Elinoff, John T. Walters, Bala Ramaswami, Geetha Chalasani, Juan M. Taboas, Fadi G. Lakkis, Diana M. Metes, Gernot Zissel Published in: PLoS ONE DOI: 10.1371/journal.pone.0176460 ABSTRACT Human monocytes have been grouped into classical (CD14++CD16−), non-classical (CD14dimCD16++), and intermediate (CD14++CD16+) subsets. Documentation of normal function and variation in this complement of subtypes, particularly their differentiation potential to dendritic cells (DC) or macrophages, remains incomplete. We therefore phenotyped monocytes from peripheral blood of healthy subjects and performed functional studies on high-speed sorted subsets. Subset frequencies were found to be tightly controlled over time and across individuals. Subsets were distinct in their secretion of TNFα, IL-6, and IL-1β in response to TLR agonists, with classical monocytes being the most producers and non-classical monocytes the least. Monocytes, particularly those of the non-classical subtype, secreted interferon-α (IFN-α) in response to intracellular TLR3 stimulation. After incubation with IL-4 and GM-CSF, classical monocytes acquired monocyte-derived DC (mo-DC) markers and morphology and stimulated allogeneic T cell proliferation in MLR; intermediate and non-classical monocytes did not. After incubation with IL-3 and Flt3 ligand, no subset differentiated to plasmacytoid DC. After incubation with GM-CSF (M1 induction) or macrophage colony-stimulating factor (M-CSF) (M2 induction), all subsets acquired macrophage morphology, secreted macrophage-associated cytokines, and displayed enhanced phagocytosis. From these studies we conclude that classical monocytes are the principal source of mo-DCs, but all subsets can differentiate to macrophages. We also found that monocytes, in particular the non-classical subset, represent an alternate source of type I IFN secretion in response to virus-associated TLR agonists. INTRODUCTION Monocytes play an important role in immune defense, inflammation, and homeostasis by sensing their local environment, clearing pathogens and dead cells, and initiating adaptive immunity, as well as providing a progenitor pool that contributes to inflammatory DCs and replenishes some tissue macrophages [1–4]. Monocytes also contribute to tissue repair, [1–7] further underscoring their relevance to both health and disease. Similar to other cell types with primary and progenitor functions, monocytes are a heterogeneous and plastic cell population, with context-dependent functions attributed to different subsets [8,9]. This has generated controversy in the literature, where functions of a specific monocyte subset responding to a specific stimulus, for example infection, in a specific site in vivo [10–15] have been extrapolated to that subset under all conditions, which is frequently inaccurate [16]. Therefore, a clearer definition of monocyte subset function is needed. Monocyte subset function has been more extensively studied in mouse models than in humans. In the mouse Ly6C+/high (Gr1+/high) or inflammatory monocytes circulate in the blood and egress into tissues following infection, at which point they differentiate into macrophages and DCs, producing inflammatory cytokines and reactive oxygen species, stimulating effector T-cell proliferation, and mediating tissue repair. These cells also contribute to a population of monocyte-derived suppressor cells that inhibit T-cell function in cancer and autoimmune models. Ly6C−/low (Gr1−/low) monocytes adopt a patrolling phenotype, characterized by long-range crawling along the luminal surface of small vessels, that allows them to survey the organism for tissue damage in the form of dying and infected cells and mediate their disposal [17–19]. Human monocyte subpopulations that correspond in phenotype and function to those present in mice are the CD14++CD16− (classical), which account for 80–90% of peripheral blood monocytes, and the CD14dimCD16++ (non-classical) subpopulations. The former corresponds to the Ly6C+/high inflammatory subset while the latter corresponds to Ly6C-/low patrolling subset in mice. Microarray-based gene expression profiling has confirmed that differential gene expression profiles observed in mouse monocyte subsets are conserved in human monocyte subpopulations [3,20–24]. However, it should be noted that many in vivo observations of patrolling monocyte function in mouse models take place during a stage when those cells are tethered to the vasculature, which may reflect a more committed state than that of non-classical human monocytes obtained via a peripheral blood draw. An intermediate CD14++CD16+ subset has also been identified in human blood, and the functions previously attributed to all CD16+ monocytes appear to be distinct for intermediate versus non-classical (CD14dim) subsets [21]. Functional observations of human monocyte subsets documented in the literature are somewhat controversial, with different responses observed depending on the context of their activation. Microarray and functional studies of human and other primate monocyte subsets in one case showed a closer association of intermediate monocytes with classical monocytes [21] and in others with non-classical monocytes [25,26]. Although there is agreement that functionally significant monocyte heterogeneity is conserved among mammals [27], further study of these subsets and their capabilities is clearly indicated. It is likely that these diverse functions attributed generally to monocytes are due to the presence of multiple monocyte subpopulations responding to activation in a variety of contexts over time [3,6,28]. A thorough understanding of the homeostasis, function, and differentiation potential of human monocyte subsets from healthy subjects is therefore a pre-requisite for establishing their roles in human disease. Such understanding should enable more specific targeting of innate responses in the setting of infection, inflammation, autoimmunity, cancer, and transplantation as well as the development of monocyte-based biomarkers that measure either disease activity or response to therapy in these conditions [29]. In the current study, we aimed at establishing a baseline understanding of how each subset of the monocyte compartment in healthy adult humans behaves under a limited set of clearly defined, well controlled, commonly used ex vivo laboratory conditions in order to uncover key differences between the three human monocyte subsets related to their hardwired function and differentiation potential. MATERIALS AND METHODS Immunophenotyping Peripheral blood was drawn from consenting healthy adult subjects with IRB approval at the University of Pittsburgh (IRB#00608014). Cell counts were obtained using a Coulter Counter Analyzer (Beckman Coulter). Monocytes were immunophenotyped in 200 μL of fresh whole blood. Non-specific binding was blocked using 10% mouse serum (Invitrogen). Cells were stained for 30 minutes with monoclonal antibodies (mAbs) against the markers described below, treated with Fix/Lyse buffer (BD Biosciences) according to the manufacturer’s protocol, and washed twice in FACS buffer (PBS supplemented with 1% FCS and 0.05% sodium azide) prior to analysis. Lymphoid cells were excluded using fluorescently preconjugated primary antibodies against lineage markers CD3, CD4, CD15, CD19, CD56, and NKp46 after exclusion of doublets and HLA-DR− cells (all from BD). Monocyte subsets were identified according to their expression of CD14 and CD16, and percent of total monocytes and absolute number was calculated for each subset. A panel of markers was interrogated for each sample using fluorescently preconjugated primary antibodies against CD11b, CD11c, CD62L, CD163, CD80, CD47, SIRPα, PD-1, PD-L1, PD-L2 (BD) and CX3CR1 (eBioscience). Marker expression was measured using a BD LSR Fortessa flow cytometer and data were analyzed using FlowJo (Tree Star). Isotype controls and/or FMO controls for each marker were used to calculate delta mean fluorescence intensity for the population. Isolation of human monocyte subsets Leukocyte concentrates were purchased from the Central Blood Bank of Pittsburgh. Red blood cells (RBC) were lysed using an ammonium chloride buffer (Stem Cell Technologies) according to the manufacturer’s protocol. PBMCs were rinsed in wash buffer twice, then incubated at 37°C in FCS containing 5mM EDTA to remove any remaining platelets [30,31]. After washing, monocytes were negatively selected using an

Read the complete text